Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, September 15, 2026

Low-Dose Digoxin Ameliorates Age-Related Motor Learning Deficits in Mice

 Consult with your doctor if you are using this for atrial fibrillation.

Low-Dose Digoxin Ameliorates Age-Related Motor Learning Deficits in Mice

Abstract

Age-related decline in motor learning has been linked to impaired synaptic plasticity in the central nervous system; however, effective pharmacological strategies to restore these processes remain limited. Here, we investigated whether low-dose digoxin improves motor learning performance and dendritic spine structural plasticity in the middle-aged mice. Behavioral analyses revealed that low-dose digoxin (4 and 65 µg/kg) enhanced motor learning performance in the rotarod task, without affecting muscle strength or spontaneous locomotor activity. At the molecular level, digoxin increased sodium-potassium ATPase (Na/K ATPase) activity in the motor cortex. Morphological analyses using Golgi–Cox staining demonstrated a selective increase in filopodia and thin-type dendritic spines, which are associated with structural remodeling. Interestingly, these changes occurred without a detectable increase in the brain-derived neurotrophic factor (BDNF) protein level in the motor cortex as assessed by western blotting. Given the established role of BDNF in synaptic plasticity, these findings suggest that the observed structural changes are not primarily mediated by the BDNF upregulation. Instead, the data are consistent with engagement of activity-dependent structural remodeling pathways, including the neurotrypsin–agrin pathway, which links synaptic activity to dendritic filopodia formation. Furthermore, agrin-derived fragments have been reported to interact with Na/K ATPase, suggesting that this fragment may function as a molecular interface between extracellular signaling and synaptic structural remodeling. Together, these results indicate that modulation of Na/K ATPase activity enhances motor learning and dendritic spine remodeling in the aged motor cortex through mechanisms that do not require increased BDNF protein levels.

This is a preview of subscription content, log in via an institution to check access.

No comments:

Post a Comment